Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.62+0.01 (+0.62%)
Close on Nov 13, 2026Market cap $60.63MP/E –Yield –
Tenax Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Tenax Therapeutics's operating margin for the twelve months ending Apr 30, 2015 was -30062.8%. For fiscal 2015 it was -30062.8%, against -10452.1% the year before. The highest annual figure on record is 10238.4% in fiscal 2011.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2015 | Apr 30, 2015 | -30062.8% | −19610.7 |
| FY2014 | Apr 30, 2014 | -10452.1% | −10016.4 |
| FY2013 | Apr 30, 2013 | -435.7% | +1823.9 |
| FY2012 | Apr 30, 2012 | -2259.7% | −12498.1 |
| FY2011 | Apr 30, 2011 | 10238.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | -10393.4% | – |
See a number that looks wrong?